Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review
Journal Title: Neurology Letters - Year 2022, Vol 1, Issue 2
Abstract
The first appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) named coronavirus disease 2019 (COVID-19) was reported from Wuhan in December 2019. While this virus displays several respiratory manifestations such as severe pneumonia and acute respiratory distress syndrome, there are several reports of nervous system involvement in the affected patients. Currently, there is a growing number of cases with central nervous system (CNS) autoimmune diseases (ADs) including autoimmune encephalitis (AE), neuromyelitis optica spectrum disorder (NMOSD), CNS vasculitis, acute disseminated encephalomyelitis (ADEM), and multiple sclerosis (MS) secondary to COVID-19 infection. Symptoms of these diseases vary from mainly drowsiness, delirium, and motor deficits in ADEM, MS, and AE and also visual impairment, and sensory problems in NMOSD and transverse myelitis patients. The severity of COVID-19 symptoms was also different from disease to disease. Based on the previous studies moderate corticosteroid therapy or other medication such as intravenous human immunoglobulins (IVIG), and plasma exchange (PLEX) is suggested for the treatment of CNS ADs in COVID patients. Also, patients with a previous history of ADs and other comorbidities such as hypertension, diabetes mellitus, hypercholesterolemia, and ischemic heart disease are at greater risk to develop severe complications of COVID compared to other patients. Current pieces of evidence demonstrated that CNS ADs can occur due to COVID-19 infection and the healthcare system should attention to CNS ADs as a complication of COVID-19. However, further investigations are strongly needed to confirm these findings.
Authors and Affiliations
Fardin Nabizadeh, Kasra Pirahesh, Fatemeh Sodeifian, Seyedeh Melika Hashemi, Mohammad Balabandian, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi
Keywords
Related Articles
- EP ID EP711703
- DOI 10.52547/NL.1.2.69
- Views 70
- Downloads 0
Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease
Alzheimer’s Disease (AD) is characterized by cognitive impairments and memory difficulties, which cause daily activities, and personal and behavioral problems. In recent years blood-based biomarkers like plasma phosphory...
Central nervous system autoimmune diseases associated with COVID-19: Comprehensive review
The first appearance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) named coronavirus disease 2019 (COVID-19) was reported from Wuhan in December 2019. While this virus displays several respiratory manif...
Transient global amnesia associated with acute bacterial endocarditis; A case report
Introduction: Transient global amnesia (TGA) is a sudden loss of memory without definite etiology. Some cardiac conditions like myocardial infarction, mitral valve prolapse, takotsubo syndrome, and arrhythmias have been...
Helicobacter Pylori specific antibodies among multiple sclerosis patients
Background:Â Multiple sclerosis (MS) is one of the most common neurological diseases that occurs predominantly in young adults and more commonly in women. MS is a chronic inflammatory disease characterized by demyelinati...
Neurology Letters is born!
On behalf of our editorial board, editorial team, authors, reviewers, and supporting institutions – we warmly welcome you to the first issue of the Neurology Letters. This is the official journal of the Neurology departm...